ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q4Scopus Q3SCImago #20,564Hybrid

Indonesian Journal of Pharmacy

Identifier (ISSN):2338-9486(Print)/2338-9427(Online)
•
Publisher:Universitas Gadjah Mada
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
0.7– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Indonesian Journal of Pharmacy

WoS Q4
00110.420230.720240.720250.72026
Annual Impact Factor Metric
Current (2026):0.7
Scopus SJR & RankScopus Q3
0.223
#20,564

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
15

15 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate14.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
73articles/year
31.58% Gold OA•75% Original Research

Aims & Scope

The journal had been established in 1972, and online publication was begun in 2008. Since 2012, the journal has been published in English by Faculty of Pharmacy Universitas Gadjah Mada (UGM) Yogyakarta Indonesia in collaboration with IAI (Ikatan Apoteker Indonesia or Indonesian Pharmacist Association) and only receives manuscripts in English. Indonesian Journal of Pharmacy is Accredited by Directorate General of Higher Education. The journal includes various fields of pharmaceuticals sciences such as: -Pharmacology and Toxicology -Pharmacokinetics -Community and Clinical Pharmacy -Pharmaceutical Chemistry -Pharmaceutical Biology -Pharmaceutics -Pharmaceutical Technology -Biopharmaceutics -Pharmaceutical Microbiology and Biotechnology -Alternative medicines.

Topics Covered (Recognized by AI)
Biology95.5%Chemistry87.8%Medicine82.9%Biochemistry70.3%Organic chemistry64.2%Internal medicine49.6%Genetics49%Pharmacology39.5%Physics39.2%Chromatography36.5%Traditional medicine32.6%Botany31.3%Endocrinology30.5%Materials science24.1%Geology23.3%Engineering22.6%Pathology22.4%Psychology21.4%Food science21.3%Paleontology20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank333/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank338/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.7
Articles / Year26
Total Citations2
2025
IF0.7
Articles / Year71
Total Citations29
2024
IF0.7
Articles / Year56
Total Citations62
2023
IF0.4
Articles / Year62
Total Citations96
2022
IF—
Articles / Year67
Total Citations239

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #20,564Scopus Q3SCImago Profile
Scopus Coverage:2016-2025
Scopus Broad Areas:Health ProfessionsMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.223

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.07

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,458 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations202
3-Year Documents176
Citable Documents176

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate55.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ3
Pharmacology (medical)Q3
PharmacyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 14.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Indonesian Journal of Pharmacy (ISSN: 2338-9486) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Universitas Gadjah Mada in Indonesia. The periodical holds a Journal Impact Factor (JIF) of 0.70, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.223 (Q3), an H-index of 15.

The journal enforces rigorous peer evaluation with an annual output of approximately 73 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,458 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Universitas Gadjah Mada
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusDOAJPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 57337b25-2d45-4e2e-9b41-2321c8cbd944
Database Updated: 2026-10-01